First Time Loading...
A

Antares Pharma Inc
NASDAQ:ATRS

Watchlist Manager
Antares Pharma Inc
NASDAQ:ATRS
Watchlist
Price: 5.59 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

ATRS Price Targets Summary
Antares Pharma Inc

There are no price targets for ATRS.
ATRS Lowest Forecast
Wall Street Target
Not Available
ATRS Average Forecast
Wall Street Target
Not Available
ATRS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Antares Pharma Inc Competitors:
Price Targets
524731
Jenburkt Pharmaceuticals Ltd
38% Downside
NEU
Neuren Pharmaceuticals Ltd
38% Upside
GRANULES
Granules India Ltd
7% Upside
CTLT
Catalent Inc
2% Upside
524731
Jenburkt Pharmaceuticals Ltd
38% Downside
NEU
Neuren Pharmaceuticals Ltd
38% Upside
GRANULES
Granules India Ltd
7% Upside
CTLT
Catalent Inc
2% Upside
N
4516
Nippon Shinyaku Co Ltd
59% Upside
H02
Haw Par Corporation Ltd
76% Upside
CGTX
Cognition Therapeutics Inc
296% Upside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
37% Downside

Revenue
Forecast

Revenue Estimate
Antares Pharma Inc

For the last 8 years the compound annual growth rate for Antares Pharma Inc's revenue is 31%. The projected CAGR for the next 2 years is 19%.

31%
Past Growth
19%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Antares Pharma Inc

Operating Income forecast
is not available for
Antares Pharma Inc

Net Income
Forecast

Net Income Estimate
Antares Pharma Inc

The compound annual growth rate of Antares Pharma Inc's net income for the next 2 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
ATRS intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATRS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATRS stock valuation using valuation multiples.
Wall Street Estimates
ATRS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATRS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRS's stock price target?
Not Available

ATRS doesn't have any price targets made by Wall Street professionals.

What is Antares Pharma Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Antares Pharma Inc's revenue is 31%. The projected CAGR for the next 2 years is 19%.

What is Antares Pharma Inc's Net Income forecast?
Projected CAGR
-10%

The compound annual growth rate of Antares Pharma Inc's net income for the next 2 years is -10%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.